Meridian Wealth Advisors, LLC Eli Lilly & CO Transaction History

Meridian Wealth Advisors, LLC

$482 Million
Q1 2024

A detailed history of Meridian Wealth Advisors, LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Meridian Wealth Advisors, LLC holds 7,113 shares of LLY stock, worth $6.44 Million. This represents 1.15% of its overall portfolio holdings.

Number of Shares

7,113

Previous 7,169 0.78%

Holding current value

$6.44 Million

Previous $4.18 Million 32.43%

% of portfolio

1.15%

Previous 0.96%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 10, 2024	SELL	$592.2 - $792.28 $33,163 - $44,367	-56 Reduced 0.78%	7,113 $5.53 Million
Q4 2023 Feb 06, 2024	BUY	$525.19 - $619.13 $1,050 - $1,238	2 Added 0.03%	7,169 $4.18 Million
Q3 2023 Nov 13, 2023	SELL	$434.7 - $599.3 $19,996 - $27,567	-46 Reduced 0.64%	7,167 $3.85 Million
Q2 2023 Aug 02, 2023	BUY	$350.74 - $468.98 $1,052 - $1,406	3 Added 0.04%	7,213 $3.38 Million
Q1 2023 May 01, 2023	BUY	$310.63 - $364.82 $31,684 - $37,211	102 Added 1.44%	7,210 $2.48 Million

Q4 2022 Jan 23, 2023	SELL	$321.55 - $374.67 $34,405 - $40,089	-107 Reduced 1.48%	7,108 $0
Q3 2022 Oct 19, 2022	BUY	$296.48 - $337.87 $65,225 - $74,331	220 Added 3.15%	7,215 $2.33 Million
Q2 2022 Jul 26, 2022	BUY	$278.73 - $327.27 $450,148 - $528,541	1,615 Added 30.02%	6,995 $2.27 Million
Q1 2022 May 12, 2022	BUY	$234.69 - $291.66 $275,760 - $342,700	1,175 Added 27.94%	5,380 $1.54 Million
Q4 2021 Feb 02, 2022	BUY	$224.85 - $279.04 $449 - $558	2 Added 0.05%	4,205 $1.16 Million
Q3 2021 Nov 12, 2021	SELL	$221.6 - $272.71 $1,108 - $1,363	-5 Reduced 0.12%	4,203 $971,000
Q2 2021 Aug 10, 2021	BUY	$180.55 - $233.54 $83,594 - $108,129	463 Added 12.36%	4,208 $966,000
Q1 2021 May 07, 2021	SELL	$164.32 - $212.72 $22,511 - $29,142	-137 Reduced 3.53%	3,745 $700,000
Q4 2020 May 07, 2021	BUY	$130.46 - $172.63 $482,180 - $638,040	3,696 Added 1987.1%	3,882 $655,000
Q4 2020 Feb 16, 2021	SELL	$130.46 - $172.63 $487,659 - $645,290	-3,738 Reduced 95.26%	186 $24,000
Q3 2020 Nov 16, 2020	BUY	$146.22 - $169.13 $7,018 - $8,118	48 Added 1.24%	3,924 $581,000
Q2 2020 Aug 14, 2020	BUY	$136.42 - $164.18 $125,233 - $150,717	918 Added 31.03%	3,876 $636,000
Q1 2020 May 15, 2020	BUY	$119.05 - $147.35 $41,667 - $51,572	350 Added 13.42%	2,958 $410,000
Q4 2019 Feb 12, 2020	BUY	$106.92 - $132.43 $42,768 - $52,972	400 Added 18.12%	2,608 $343,000
Q3 2019 Nov 08, 2019	BUY	$106.79 - $116.16 $235,792 - $256,481	2,208 New	2,208 $247,000
Q2 2019 Aug 08, 2019	SELL	$110.79 - $129.32 $193,439 - $225,792	-1,746 Closed	0 $0
Q1 2019 May 07, 2019	BUY	$111.31 - $131.02 $11,131 - $13,102	100 Added 6.08%	1,746 $227,000
Q4 2018 Feb 14, 2019	BUY	$105.9 - $118.64 $174,311 - $195,281	1,646 New	1,646 $190,000

Others Institutions Holding LLY

# of Institutions

3,719

Shares Held

738M

Call Options Held

7.09M

Put Options Held

7.24M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $860B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Meridian Wealth Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Meridian Wealth Advisors, LLC with notifications on news.

Account

Meridian Wealth Advisors, LLC Eli Lilly & CO Transaction History